Overview / Abstract: |
Target Audience Program Overview CONTENT AREAS Pathogenesis Learning Objectives Explain how the target pathways of systemic treatment for advanced basal cell carcinoma (BCC) align with the current understanding of the pathogenesis of the disease |
Expiration |
Feb 17, 2022 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
2.0 |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Karl D. Lewis, MD |
Sponsors / Supporters / Grant Providers |
Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme |
Keywords / Search Terms |
Relias LLC Relias, Free CME, Basal Cell Carcinoma Free CE CME |